期刊文献+

喹唑啉类化合物抗癌活性研究进展 被引量:5

Research Progress in Quinazoline Derivatives with Anticancer Activity
原文传递
导出
摘要 喹唑啉环是一种优势骨架结构,可与多种生物大分子结合,产生不同的生物活性,特别是喹唑啉类化合物在抗肿瘤药物研究领域表现尤为突出。通过查阅国内外相关文献,综述近5年来具有抗癌活性的喹唑啉类化合物的国内外研究进展,按照不同喹唑啉环类型分为5类,分别介绍了各类含喹唑啉环化合物的抗癌生物活性,以便更好地利用现有条件设计合成出活性更好选择性更高的抗癌药物。 Quinazoline ring, as a key skeleton structure, can produce a variety of biological activities after combining with multi- kinds of biological macromolecules. Quinazoline compounds have played particularly important roles in the discovery of anticancer drugs. The progress in quinazoline derivatives with anticancer activity was reviewed in this paper. Quinazoline compounds were classified into five types according to different substituent groups. The bioactivities of substituent groups containing quinazoline ring were discussed. And the development trend as well as the prospect of quinazoline derivatives with anticancer activity is summarized.
出处 《中国药学杂志》 CAS CSCD 北大核心 2016年第11期867-874,共8页 Chinese Pharmaceutical Journal
基金 山东省自然科学基金资助项目(ZR2013BM006)
关键词 喹唑啉 喹唑啉酮 抗癌活性 生物活性 quinazoline quinazolinone anticancer activity biological activity
  • 相关文献

参考文献38

  • 1MCLAUGHLIN N P,EVANS P.Dihydroxylation of vinyl sulfones:stereoselective synthesis of (+)- and (-)-febrifugine and halofuginone [J].J Org Chem,2010,75(2):518-521.
  • 2MANJULA S N,BHARAT E N,DIVYA B.Medicinal and biological significance of quinazoline:a highly important scaffold for drug discovery:a review [J].Int J Pharm Bio Sci,2011,2(1):780-809.
  • 3YANG S H,KHADKA D B,CHO S H,et al.Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors [J].Bioorg Med Chem,2011,19(12):968-977.
  • 4刘丹,栾天,袁莹,张磊.多靶点酪氨酸激酶抑制剂阿法替尼及其类似物的研究进展[J].中国药学杂志,2014,49(24):2145-2149. 被引量:18
  • 5KHAN I,IBRAR A,AHMED W,et al.Synthetic approaches,functionalization and therapeutic potential of quinazoline and quinazolinone skeletons:the advances continue [J].Eur J Med Chem,2015,90(1):124-169.
  • 6AL-OMARY F A M,HASSAN G S,EL-MESSERY S M,et al.Substituted thiazoles V.Synthesis and antitumor activity of novel thiazolo[2,3-b] quinazoline and pyrido[4,3-d] thiazolo[3,2-a]pyrimidine analogues [J].Eur J Med Chem,2012,47(1):65-72.
  • 7HU S J,XIE G J,ZHANG D X,et al.Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors [J].Bioorg Med Chem Lett,2012,22(19):6301-6305.
  • 8CHEN X F,DU Y G,SUN H L,et al.Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quinazolines.Part 1:erlotinib analogs [J].Bioorg Med Chem Lett,2014,24(3):884-887.
  • 9AL-OMARY F A M,HASSAN G S,EL-MESSERY S M,et al.Nonclassical antifolates,part 3:synthesis,biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones [J].Eur J Med Chem,2013,63(1):33-45.
  • 10AL-RASHOOD S T,HASSAN G S,EL-MESSERY S M,et al.Synthesis,biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolylthio and 4-methylthiazolylthio) quinazolin-4-ones as a new class of DHFR inhibitors [J].Bioorg Med Chem Lett,2014,24(18):4557-4567.

二级参考文献46

  • 1张文婷,鄢浩,姜凤超.聚腺苷二磷酸核糖聚合酶-1抑制剂药效团模型的建立[J].药学学报,2007,42(3):279-285. 被引量:3
  • 2CIARDIELLO F, CAPUTO R,BIANCO R. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD 1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor [ J ]. J Clin Cancer Res, 2000,6 ( 5 ) : 2053 -2063.
  • 3CIARDIELLO F. Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents [ J]. J Drugs,2000,60:25-32.
  • 4HARARI P M,ALLEN G W, BONNER J A. Biology of interac- tions: antiepidermal growth factor receptor agents [ J]. J Clin On- col ,2007,25 ( 26 ) :4057-4065.
  • 5CHANG T,MEI D,ZHANG L, et al. Novel antitumor drug- ge- fitinib[J].中国中药杂志 ,2006,41 (12) :958- 959.
  • 6GIBSON K H, BRUNDY W, GODFREY A A, et al. Epidermal growth factor receptor tyrosine kinase: structure-activity relation- ships and antitumor activity of novel quinazolines [ J ]. Bioorg Med Chem Lett, 1997,7 ( 21 ) : 2723-2728.
  • 7DEJESUS O T, MURALI D, FLORES L G, et al. Synthesis of [ ^18F] -ZD1839 as a PET imaging agent for epideImal growth fac- tor receotors [J].J Label Comod Radiooharm.2003.46( 1 ) ,25.
  • 8WANG J Q,GAO M Z,MILLER K D,et al. Synthesis of[ ^11C] iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase [ J ] . Bioorg Med Chem Lett ,2006,16 ( 15 ) :4102-4106.
  • 9BOSCHELLI D H,YE F,WANG Y D,et al. Optimization of 4- phenylamino-3-quinolineearbonitriles as potent inhibitors of sre kinase activity [J]. J Med Chem, 2001,44 (23) :3965-3977.
  • 10JI M,ZHENG Y G, LI M D. Production method of gefitinib: Chi- na,CN101148439A[ P]. 2008-03-26.

共引文献27

同被引文献26

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部